Home / Products / Pharmaceuticals / GLIMIHAB MP1 TABLETS
- Division
- Pharmaceuticals
- Brand
GLIMIHAB MP1 TABLETS
Composition: Each uncoated sustained release tablet contains:
Glimepiride IP ………………… 1 mg
Pioglitazone …… 15 mg
Metformin Hydrochloride IP (SR) …… 500 mg
Inclusive of all taxes
| Pack size | 10 per strip |
|---|---|
| Dosage form | TABLETS |
| Category | Diabetes Care |
| Storage | Store in a cool, dry place below 30°C. Protect from light and moisture. Keep in the original packaging until use. Keep out of reach of children. |
| Product code | GGLIMI0256 |
Uses / indications
- Management of type 2 diabetes
Product information
Glimepiride 1 mg + Pioglitazone 15 mg + Metformin SR 500 mg
How It Helps:
Helps control blood glucose levels through three complementary mechanisms. Glimepiride stimulates insulin release from the pancreas, pioglitazone improves the body's sensitivity to insulin, and metformin reduces glucose production in the liver.
Indications:
Used to improve blood glucose control in adults with type 2 diabetes mellitus, along with diet and exercise, as prescribed by a physician.
Directions for Use:
Take orally with food, as directed by the physician. Swallow the sustained-release tablet whole; do not crush or chew it.
Medical Advice:
Consult a doctor for proper evaluation and guidance on the suitability, dosage, and duration of treatment.
More from Haibo Prime
DYCLOBA PAIN RELIEF GEL
Each gram of gel contains: Diclofenac Diethylamine IP …… 1.16% w/w (equivalent to Diclofenac Sodium IP 1.0% w…
More from Pharmaceuticals
EMPAHAB 10 TABLETS
Each film-coated extended-release tablet contains : Empagliflozin IP Equivalent to Empagliflozin ............…
SITAHAB GM2 FORTE
Sitagliptin equivalent to 50 mg + Glimepiride 2 mg + Metformin Hydrochloride 1000 mg
SITAHAB MET 50/500 TABS
Sitagliptin equivalent to 50 mg + Metformin Hydrochloride 500 mg